SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet–Induced Obese Mice
Antioxidants & Redox Signaling · 2024
DOI: 10.1089/ars.2022.0156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2024. Verfasst von Ting Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Aims
Obese patients are highly sensitive to adriamycin (ADR)-induced cardiotoxicity. However, the potential mechanism of superimposed toxicity remains to be elucidated. Sestrin 2 (SESN2), a potential antioxidant, could attenuate stress-induced cardiomyopathy; therefore, this study aims to explore whether SESN2 enhances cardiac resistance to ADR-induced oxidative damage in high-fat diet (HFD)–induced obese mice.
Results
The results revealed that obesity decreased SESN2 expression in ADR-exposed heart. And, HFD mice may predispose to ADR-induced cardiotoxicity, which was probably associated with inhibiting protein kinase B (AKT), glycogen synthase kinase-3 beta (GSK-3β) phosphorylation and subsequently blocking nuclear localization of nuclear factor erythroid-2 related factor 2 (NRF2), ultimately resulting in cardiac oxidative damage. However, these destructive cascades and cardiac oxidative damage effects induced by HFD/sodium palmitate combined with ADR were blocked by overexpression of SESN2. Moreover, the antioxidant effect of SESN2 could be largely abolished by sh- Nrf2 or wortmannin. And sulforaphane, an NRF2 agonist, could remarkably reverse cardiac pathological and functional abnormalities caused by ADR in obese mice. Innovation and Conclusion: This study demonstrated that SESN2 might be a promising therapeutic target for improving anthracycline-related cardiotoxicity in obesity by upregulating activity of NRF2 via AKT/GSK-3β/Src family tyrosine kinase signaling pathway. Antioxid. Redox Signal. 40, 598–615.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Cardiology at the First Hospital of Jilin University, Changchun, China.
- Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- Department of Cardiology at the First Hospital of China Medical University, Shenyang, China.
- Department of Cardiology at the People's Hospital of Liaoning Province, Shenyang, China.
- Department of Nursing, Shaanxi Provincial People's Hospital, Xi'an, China.
ORCID-Profile: Junlian Gu
Zitieren
APA
Gao, T., Wang, J., Xiao, M., Wang, J., Wang, S., Tang, Y., Zhang, J., Lu, G., Guo, H., Guo, Y., Liu, Q., Li, J., & Gu, J. (2024). SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet–Induced Obese Mice. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2022.0156
Vancouver
Gao T, Wang J, Xiao M, Wang J, Wang S, Tang Y, et al. SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet–Induced Obese Mice. Antioxidants & Redox Signaling. 2024. doi:10.1089/ars.2022.0156
BibTeX
@article{Gao2024,
author = {Gao, Ting and Wang, Jie and Xiao, Mengjie and Wang, Jie and Wang, Shudong and Tang, Yufeng and Zhang, Jingjing and Lu, Guangping and Guo, Hua and Guo, Yuanfang and Liu, Qingbo and Li, Jiahao and Gu, Junlian},
title = {SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet–Induced Obese Mice},
journal = {Antioxidants & Redox Signaling},
year = {2024},
doi = {10.1089/ars.2022.0156}
}
EUVIMED